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Abstract
Introduction: Early and aggressive volume resuscitation is fundamental in the treatment of hemodynamic
instability in critically ill patients and improves patient survival. However, one important consequence of fluid
administration is the risk of developing fluid overload (FO), which is associated with increased mortality in patients
with acute kidney injury (AKI). We evaluated the impact of fluid balance on mortality in intensive care unit (ICU)
patients with AKI.
Methods: The data were extracted from the Beijing Acute Kidney Injury Trial. This trial was a prospective,
observational, multicenter study conducted in 30 ICUs among 28 tertiary hospitals in Beijing, China, from 1 March
to 31 August 2012. In total, 3107 patients were admitted consecutively, and 2526 patients were included in this
study. The data from the first 3 sequential days were analyzed. The AKI severity was classified according to the
Kidney Disease: Improving Global Outcomes guidelines. The daily fluid balance was recorded, and the cumulative
fluid balance was registered at 24, 48, and 72 h. A multivariate analysis was performed with Cox regression to
determine the impact of fluid balance on mortality in patients with AKI.
Results: Among the 2526 patients included, 1172 developed AKI during the first 3 days. The mortality was 25.7 %
in the AKI group and 10.1 % in the non-AKI group (P < 0.001). The daily fluid balance was higher, and the
cumulative fluid balance was significantly greater, in the AKI group than in the non-AKI group. FO was an
independent risk factor for the incidence of AKI (odds ratio 4.508, 95 % confidence interval 2.900 to 7.008, P < 0.001)
and increased the severity of AKI. Non-surviving patients with AKI had higher cumulative fluid balance during the
first 3 days (2.77 [0.86–5.01] L versus 0.93 [−0.80 to 2.93] L, P < 0.001) than survivors did. Multivariate analysis
revealed that the cumulative fluid balance during the first 3 days was an independent risk factor for 28-day
mortality.
Conclusions: In this multicenter ICU study, the fluid balance was greater in patients with AKI than in patients
without AKI. FO was an independent risk factor for the incidence of AKI and increased the severity of AKI. A higher
cumulative fluid balance was an important factor associated with 28-day mortality following AKI.
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Introduction
Early fluid resuscitation to expand intravascular volume
and maintain organ perfusion is a core concept in the
management of critical illness [1–4]. However, fluid ad-
ministration increases the risk of fluid overload (FO).
Clinically, FO manifests as an expansion of interstitial
space and increased venous pressure, resulting in tissue
edema, organ dysfunction [5–9], and adverse outcomes
[10, 11].
Congestion and increased venous pressure lead to in-
creased renal subcapsular pressure and lowered renal
blood flow and glomerular filtration rate (GFR) [12].
The association between FO, the development of the ab-
dominal compartment syndrome (ACS), and the occur-
rence of acute kidney injury (AKI) is well known [13].
Some investigators have observed that FO remained in-
dependently associated with adverse outcomes in pa-
tients with AKI after accounting for the confounding
effects of illness severity and hemodynamic instability
[14–16].
In a study done by the Program to Improve Care in
Acute Renal Disease (PICARD) group, the adjusted odds
ratio (OR) for mortality was 2.07 in patients with FO at
initiation of renal replacement therapy (RRT). In this
population, survivors who were taken off RRT showed
significantly less FO than did patients who remained on
RRT [17]. Recently, a reanalysis of the data from the
Randomized Evaluation of Normal vs. Augmented Level
of Replacement Therapy study demonstrated that, in pa-
tients with AKI requiring RRT in the intensive care unit
(ICU), a negative mean daily fluid balance was independ-
ently associated with a decreased risk of death and with
more ICU-free and hospital-free days [18]. FO is probably
a severity marker or an independent factor for higher
mortality in critically ill patients.
To date, there has been no multicenter study con-
ducted on patients with AKI of Chinese descent. Thus,
in our present study, we evaluated the impact of fluid
balance on mortality in Chinese adult ICU patients
with AKI.
Material and methods
Study design and data collection
In this study, we used a database from a prospective,
multicenter, observational study in which investigators
examined the epidemiology of AKI in critically ill pa-
tients at 30 ICUs among 28 tertiary hospitals in Beijing,
China, from 1 March to 31 August 2012 (the Beijing
Acute Kidney Injury Trial [BAKIT]) [19]. For a complete
list of these hospitals and the persons responsible for the
data acquisition, see Additional file 1. Study subjects in-
cluded all adult patients (age ≥18 years) admitted con-
secutively to ICUs. Only the initial ICU admission was
considered in this study. The following patients were ex-
cluded: patients with preexisting end-stage chronic kid-
ney disease, patients already undergoing RRT before
admission to the ICU, and patients who had received
kidney transplants in the previous 3 months. Preexisting
comorbidities were diagnosed based on International
Classification of Diseases, Tenth Revision, codes. Among
the 3107 patients who were admitted consecutively,
2526 patients with their first 3 days of sequential data
were included in our study (Fig. 1).
The collected data included demographics, anthropo-
metrics, admission diagnosis, comorbidities, daily vital
signs, and laboratory values, which were to calculate
Fig. 1 Study flowchart with 28-day mortality rate. AKI acute kidney injury, ICU intensive care unit, RRT renal replacement therapy
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automatically the Acute Physiology and Chronic Health
Evaluation II (APACHE II) [20], the Simplified Acute
Physiology Score II (SAPS II) [21], and the Sequential
Organ Failure Assessment (SOFA) score [22]. RRT and
mortality data were also reported. Furthermore, hourly
urine output, fluid balance, and use of diuretics were re-
corded daily. Fluid balance was calculated daily as the
difference between fluid intake and fluid output. Fluid
output included all body fluids, including urine, excre-
ment, and, if applicable, dialysis ultrafiltrate. The pa-
tients were followed until death, hospital discharge, or
for 28 days.
This study was approved by the institutional review
board of the ethics committee of the lead study center (Fu
Xing Hospital, Capital Medical University, Beijing China)
and all other participating hospitals (see Additional
file 2). The requirement for informed consent was
waived for this observational survey. The patient re-
cords and information were anonymized and deidenti-
fied before analysis.
Definitions
The AKI cohort consisted of patients who developed
AKI within the first 72 h. Patients who developed AKI
after the third day (e.g., on day 4) were classified as non-
AKI. AKI severity was classified according to the Kidney
Disease: Improving Global Outcomes (KDIGO) guide-
lines [23]. AKI was staged for severity (stages 1, 2, and
3) based on serum creatinine (SCr) or urine output or
both. Baseline creatinine was defined as the lowest
known SCr value during the previous 3 months [24]. For
patients without these values or without renal failure,
the baseline SCr was estimated by using the Modifica-
tion of Diet in Renal Disease equation [25], assuming a
GFR of 75 ml/min/1.73 m2 [26]. For patients with
chronic renal failure but not receiving dialysis, the initial
SCr value upon admission was used as the baseline value
[26]. We regarded the worst stage during the first 3 days
as the AKI stage.
Oliguria was defined as urine output less than 500 ml/
day. The daily fluid balance was recorded, and the cu-
mulative fluid balance was registered at 24, 48, and 72 h.
We calculated the daily AKI numbers when we com-
pared daily fluid balance between the AKI and non-AKI
groups, but we included all patients with AKI in the first
3 days when we compared the cumulative fluid balance.
To quantify the cumulative fluid balance over 3 days in
relation to body weight, we used the following formula:
sum of daily (fluid intake [liters] − total output [liters])/
body weight (kilograms). We used the term percentage
of fluid accumulation to define the percentage of cumu-
lative fluid balance adjusted for body weight. Baseline
body weight was recorded at initial hospital admission.
We defined FO as fluid accumulation greater than 10 %
of the baseline weight [27].
Statistical analysis
Non-normally distributed continuous variables were
expressed as median with interquartile range (IQR) and
were compared using the Mann–Whitney U test or the
Kruskal–Wallis analysis of variance test with the Bonfer-
roni correction. Categorical variables were expressed as
the number of cases and proportions and were com-
pared using the Mantel–Haenszel χ2 test. We used a lo-
gistic regression model to evaluate the effect of FO on
the incidence of AKI. We conducted exploratory univar-
iate analysis of several variables to identify possible con-
founders associated with 28-day mortality and to assess
the influence of cumulative fluid balance on the survival
time of patients with AKI. A multivariate Cox regression
analysis was then performed using a backward stepwise
selection method, with a P value less than 0.05 as the
entry criterion and a P value 0.10 or higher as the re-
moval criterion. The assumption of proportional hazards
was checked graphically using log (−log [survival prob-
ability) plots and was found to be appropriate. Variables
considered for multivariable analysis included age, co-
morbid diseases, diagnosis, illness severity scores, cumu-
lative fluid balance at 72 h, oliguria, and sepsis (similarly
to a previous study) [28]. We tested for colinearity
among all variables using a Cox regression analysis to
generate hazard ratios and 95 % confidence intervals
(CIs). The 28-day survival stratified by the presence or
absence of FO was additionally evaluated graphically
using the Kaplan–Meier product limit survival plot. All
statistical analyses were performed using IBM SPSS
17.0 software package (IBM, Armonk, NY, USA), with a




Among the 3107 patients enrolled in the BAKIT study,
581 were excluded because of incomplete data covering
the first 3 days following ICU admission, leaving 2526
patients for analysis. The characteristics of the entire co-
hort are shown in Table 1. The mean age was 64.0
(51.8–77.0) years, and 62.5 % were men. All-cause 28-
day mortality was 17.3 %, and mean ICU length of stay
was 6.0 (4.0–11.0) days. Of these patients, 1172 (46.4 %)
developed AKI during the first 3 days following ICU
admission. Patients with AKI were older (P < 0.001) and
had higher illness severity scores than patients without
AKI. Patients with AKI were more likely to present with
sepsis upon ICU admission. The daily fluid balance and
cumulative fluid balance at 24, 48, and 72 h were lower
in the patients without AKI. Diuretics were used more
Wang et al. Critical Care  (2015) 19:371 Page 3 of 11
commonly in patients with AKI (74.4 % versus 46.4 %;
P < 0.001). The 28-day mortality was higher among pa-
tients with AKI (25.7 % versus 10.1 %; P < 0.001).
Characteristics of patients with AKI
The characteristics of patients with AKI according to
outcome are shown in Table 2. Non-surviving patients
with AKI were older (P < 0.001), had higher illness sever-
ity scores, and were more likely to be diagnosed with
sepsis than the other groups. The cumulative fluid
balance during the first 3 days was higher among non-
survivors (2.77 [0.86–5.01] L versus 0.93 [−0.80 to 2.93] L;
P < 0.001). Oliguria was also more common in non-
survivors (16.6 % versus 5.3 %; P < 0.001) than in patients
with AKI who survived.
Fluid balance and the incidence of AKI
The patients with AKI manifested higher daily fluid bal-
ance than patients without AKI (P < 0.01) (Fig. 2). We
included all patients with AKI during the first 3 days
when comparing cumulative fluid balance, and patients
with AKI consistently showed higher cumulative fluid
balance at 24, 48, and 72 h following ICU admission
than patients without AKI (Fig. 3).
We evaluated the effect of FO on the occurrence of
AKI in the entire cohort. According to a multivariable
model, FO increased the incidence of AKI distinctly (OR
4.508, 95 % CI 2.900–7.008, P < 0.001) (see Additional
file 3: Table S1).
We classified the percentage of fluid accumulation
into four levels: loss or negative, 0–5.0 % gain, 5.1–10 %
gain, and greater than 10 % gain. We found that with
the increase in fluid accumulation, the distribution of
AKI severity was also changed. However, there was no
significant difference between the first three groups.
When the fluid volume was more than 10 %, the per-
centage of patients in AKI stage 1 decreased significantly
and patients in AKI stage 3 increased significantly (P <
0.001) (see Additional file 3: Figure S1).
Fluid balance and the mortality of patients with AKI
Our study demonstrated the pattern of cumulative fluid
balance in survivors and non-survivors among patients
with AKI during the first 3 days in the ICU (Fig. 4). The
cumulative fluid balance over 3 days among the AKI sur-
vivors was 0.93 (−0.80 to 2.93) L and 2.77 (0.86–5.01) L
(P < 0.001) in the AKI non-survivors. Non-survivors also
showed higher cumulative fluid balance at 24, 48, and
72 h with significant differences.
When we stratified the patients with AKI by fluid ac-
cumulation in 3 days relative to baseline weight (Fig. 5),
the mortality increased among patients with more accu-
mulated fluid. The mortality of patients with negative
fluid balance was the lowest.
In the multivariate Cox regression analysis (Table 3),
age, SAPS II score, cumulative fluid balance over 3 days,
RRT, and sepsis were independent predictors of 28-day
mortality. The presence of FO was associated with a
higher risk of death (Fig. 6). When FO occurred, the
mortality of patients without AKI and those with AKI
increased from 9.6 % to 33.3 % (P = 0.001) and from
Table 1 Patient characteristics of all patients and compared between patients with and patients without acute kidney injury
Characteristics All (n = 2526) AKI (n = 1172) Non-AKI (n = 1354) P value
Age (yr) 64 (52–77) 67 (54–78) 63 (50–75) <0.001
Male sex 1578 (62.5) 742 (63.3) 836 (61.7) 0.434
APACHE II score 14 (10–20) 17 (12–23) 13 (9–17) <0.001
SAPS II score 34 (26–46) 40 (31–52) 31 (24–39) <0.001
SOFA score 6 (4–9) 7 (5–10) 5 (3–7) <0.001
Vasoactive therapy 1009 (40.0) 576 (49.1) 433 (32.0) <0.001
Mechanical ventilation 1702 (67.4) 818 (69.8) 884 (65.3) 0.017
Baseline creatinine (μmol/L) 81.9 (69.0–96.0) 84.9 (73.0–97.0) 79.8 (66.8–95.0) <0.001
Sepsis 808 (32.0) 512 (43.7) 296 (21.9) <0.001
Fluid balance within 24 h (L) 0.57 (−0.19 to 1.43) 0.64 (−0.20 to 1.70) 0.53 (−0.18 to 1.30) <0.001
Fluid balance within 48 h (L) 0.88 (−0.37 to 2.30) 1.06 (−0.38 to 2.82) 0.73 (−0.37 to 1.91) <0.001
Fluid balance within 72 h (L) 1.12 (−0.48 to 2.86) 1.40 (−0.49 to 3.54) 0.91 (−0.48 to 2.44) 0.001
Use of diuretics (%) 1500 (59.4) 872 (74.4) 628 (46.4) <0.001
28-day mortality 438 (17.3) 301 (25.7) 137 (10.1) <0.001
Length of ICU stay (days) 6 (4–11) 7 (5–14) 5 (4–9) <0.001
Data are expressed as median (interquartile range) or number (percent)
AKI acute kidney injury, ICU intensive care unit, APACHE II Acute Physiology and Chronic Health Evaluation II, SAPS II Simplified Acute Physiology Score II,
SOFA Sequential Organ Failure Assessment
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23.4 % to 49.1 %, respectively (P < 0.001) (see Additional
file 3: Figure S2).
Discussion
We investigated the influence of fluid balance on out-
comes among critically ill patients with AKI in a large,
multicenter, observational study involving 30 ICUs. Pa-
tients who developed AKI were older, more severely ill,
and more frequently presented with sepsis upon ICU
admission than patients without AKI. The mortality
rates were higher among patients with AKI than in those
without AKI, particularly in patients with oliguria. The
daily fluid balance was higher in the AKI group than in
the non-AKI group. Patients with AKI consistently had
higher cumulative fluid balance at 24, 48, and 72 h fol-
lowing ICU admission than patients without AKI. The
cumulative fluid balance over 3 days was significantly
higher among non-surviving patients with AKI and was
significantly associated with increased 28-day mortality
in patients with AKI.
The fluid balance was higher in patients with AKI. Ac-
cording to the multivariable model, the presence of FO
Table 2 Characteristics of patients with acute kidney injury, by outcome
Characteristics AKI (n = 1172) Survivors (n = 871) Non-survivors (n = 301) P value
Male sex 742 (63.3) 548 (62.9) 194 (64.5) 0.677
Age (yr) 67 (54–78) 64 (52–77) 74 (60–82) <0.001
ICU admission
APACHE II score 17 (12–23) 15 (11–21) 23 (17–29) <0.001
SAPS II score 40 (31–52) 37 (28–47) 52 (41–64) <0.001
SOFA score 7 (5–10) 7 (4–10) 9 (7–12) <0.001
Vasoactive therapy 576 (49.1) 419 (48.1) 157 (52.2) 0.229
Mechanical ventilation 818 (69.8) 614 (70.5) 204 (67.8) 0.383
Baseline creatinine (μmol/L) 84.9 (73.0–97.0) 84.0 (72.1–97.0) 86.9 (75.0–97.8) 0.78
Sepsis 512 (43.7) 309 (35.5) 203 (67.4) <0.001
Comorbid diseases
Cancer 164 (14.0) 112 (12.9) 52 (17.2) 0.067
Hypertension 523 (44.6) 379 (43.5) 144 (47.8) 0.202
Cardiovascular 274 (23.4) 177 (20.3) 97 (32.2) <0.001
Chronic kidney disease 111 (9.5) 79 (9.1) 32 (10.6) 0.493
Diabetes 240 (20.5) 173 (19.9) 67 (22.2) 0.407
Category of ICU admission diagnosis
Respiratory 208 (17.7) 125 (14.4) 83 (27.6) <0.001
Neurologic 178 (15.2) 134 (15.4) 44 (14.6) 0.781
Postsurgery 556 (47.4) 443 (50.8) 113 (37.5) <0.001
Cardiovascular 233 (19.9) 170 (19.5) 63 (20.9) 0.615
ICU course
Cumulative fluid balance in 3 days (L) 1.40 (−0.49 to 3.54) 0.93 (−0.80 to 2.93) 2.77 (0.86–5.01) <0.001
Oliguria 96 (8.2) 46 (5.3) 50 (16.6) <0.001
Use of diuretics (%) 872 (74.4) 635 (72.9) 237 (78.7) 0.047
Outcomes
AKI stage
1 496 (42.3) 424 (48.7) 72 (23.9)
2 289 (24.7) 215 (24.7) 74 (24.6) <0.001
3 387 (33.0) 232 (26.6) 155 (51.5)
RRT 222 (18.9) 125 (14.4) 97 (32.2) <0.001
Length of ICU stay (days) 7 (5–14) 7 (4–13) 8 (6–14) 0.001
Data are expressed as median (interquartile range) or number (percent)
AKI acute kidney injury, SAPS II Simplified Acute Physiology Score II, SOFA Sequential Organ Failure Assessment, APACHE II Acute Physiology and Chronic Health
Evaluation II, RRT renal replacement therapy
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Fig. 2 Daily fluid balance in acute kidney injury (AKI) and non-AKI in the first 3 days of intensive care unit (ICU) stay (mean ± standard error of the
mean). *P = 0.007; **P < 0.001. n1 represents patients with AKI; n2 represents patients without AKI
Fig. 3 Cumulative fluid balance in acute kidney injury (AKI) and non-AKI at 24, 48, and 72 h of intensive care unit (ICU) stay (mean ± standard
error of the). **P < 0.001
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Fig. 4 Cumulative fluid balance in acute kidney injury (AKI) survivors and non-survivors in the first 3 days of their intensive care unit (ICU) stay
(mean ± standard error of the mean). **P < 0.001
Fig. 5 Mortality rate by fluid accumulation in 3 days relative to baseline weight in patients with acute kidney injury. P value is the result of
comparing the neighboring groups. *P < 0.05; **P < 0.001
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increased the incidence of AKI distinctly. However, we
could not determine the relationship between a positive
fluid balance and the incidence of AKI, because we failed
to determine the fluid balance before ICU admission,
which might have influenced the incidence of AKI and
outcomes. The findings of the present study should
stimulate further research to investigate the role of fluid
balance on the incidence of AKI.
In fact, several lines of evidence suggest that fluid ther-
apy, rather than preserving renal function, actually precip-
itates or worsens AKI by causing FO. Positive fluid
balance triggers AKI after cardiac surgery [29, 30]. On the
contrary, the use of goal-directed therapy (GDT) strategies
for perioperative hemodynamic optimization have been
associated with decreased surgical complications [31–33]
and reduced risk of postoperative AKI [34]. Prowle et al.
reviewed 24 studies and found that GDT in surgery was
associated with a significantly lower incidence of AKI (OR
0.59, 95 % CI 0.39–0.89, P = 0.013; n = 24 studies, n = 2763
patients) [35].
In our study, FO affected the incidence of AKI and the
severity of AKI. AKI severity increased significantly
when the fluid volume was more than 10 %. The degree
of FO has also been suggested as an index of AKI sever-
ity in pediatric patients [36]. However, the cutoff value is
not clear, because an elaborate ROC curve analysis
would be required.
In our study, fluid accumulation was associated with
adverse outcomes in patients with AKI, and this finding
is consistent with those of prior studies. Teixeira et al.
performed a secondary analysis of data from a multicen-
ter, prospective cohort study in 10 Italian ICUs [28] in-
cluding 601 patients. They found that mean fluid
balance (MFB) was higher (P = 0.008) in patients with
AKI. When analyzing the subgroups separately by 28-
day mortality, non-survivor patients with AKI had sig-
nificantly higher MFB than survivors. In a multicenter,
prospective, observational study with 296 patients from
17 ICUs, Vaara et al. also reported that FO in renal sup-
port therapy (RST) was associated with a higher risk of
death at 90 days (OR 2.6) after adjustment for severity of
illness, RST onset time, RST modality, and sepsis [37].
The Sepsis Occurrence in Acutely Ill Patients study in-
vestigators found that FO in septic patients with AKI
Table 3 Multivariate Cox regression analysis of 28-day mortality
in critically ill patients with acute kidney injury
Characteristic Hazard ratio 95 % CI P value
Age 1.013 1.005–1.020 0.002
SAPS II 1.021 1.014–1.029 <0.001
Cumulative fluid balance in 3 days 1.041 1.012–1.072 0.006
Sepsis 1.278 0.961–1.701 0.092
Postsurgery 0.760 0.595–0.971 0.028
CRRT 3.166 2.463–4.069 <0.001
CI confidence interval, CRRT continuous renal replacement therapy, SAPS II
Simplified Acute Physiology Score II
Fig. 6 Survival curve of 28-day mortality by the presence or absence of fluid overload (FO) in the patients with acute kidney injury in the intensive
care unit (ICU)
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was associated with higher mortality at 60 days [15].
Several other studies also showed positive fluid balance
increased mortality among ICU patients [38–41].
The relationship of fluid accumulation and mortality
associated with AKI is complex. It is not possible to de-
termine whether the positive fluid balance found in pa-
tients with AKI was the cause or the result of a greater
severity of illness. Perhaps there was a higher severity of
illness and hypotension among those who received more
fluids, which are well-known clinical risk factors for AKI
and mortality. There are many factors that affect the
prognosis of patients with AKI, and we needed to rule
out confounding factors and perform a propensity ana-
lysis to further explore this issue.
When we stratified the patients with AKI by fluid ac-
cumulated during the first 3 days, we found that greater
fluid accumulation increased mortality among patients
with AKI. In contrast, the mortality of patients with a
negative fluid balance was the lowest. Our findings are
in agreement with reports of a number of previous stud-
ies. Bouchard et al. [17] evaluated the adult population
with AKI in the PICARD study and found that, at the
time of AKI diagnosis, the percentage of fluid accumula-
tion in relation to the patient’s weight upon ICU admis-
sion was lower among survivors than non-survivors (P =
0.01). When the rate of fluid accumulation of all patients
was greater than 10 %, the mortality at 30 and 60 days
climbed from 25 % to 37 % (P = 0.02) and from 35 % to
48 % (P = 0.01), respectively. Patients who maintained
fluid accumulation during their hospitalization showed
higher mortality proportional to fluid buildup (P <
0.001). Vaara et al. [37] demonstrated a direct associ-
ation between cumulative FO at RRT initiation and an
increased risk of 90-day mortality. Researchers in a
pediatric study also found a 3 % increase in mortality for
every 1 % increase in FO. Children with more than 20 %
FO had an OR for mortality of 8.5 compared with chil-
dren with less than 20 % FO [42].
RRT might be effective in reducing FO and increasing
survival. However, in our study, RRT was an independ-
ent risk factor for 28-day mortality (Table 3). The mor-
tality of patients treated with RRT was higher (see
Additional file 3: Table S2). This finding may be ex-
plained partly by increased illness severity upon ICU ad-
mission. Our findings in this regard are consistent with
those of other studies [15, 43].
This study is unique in providing detailed insights
into fluid balance and mortality in critically ill patients
with AKI in Beijing, China. Compared with previous
studies, we defined and classified AKI severity accord-
ing to the KDIGO criteria, reducing underestimation or
late recognition of AKI. In addition, the study subjects
with 3-day sequential data included in our study may
decrease selection bias, and the results are thus more
credible than in other studies. Our study provides
insight into the significance of fluid accumulation in
terms of degree and duration.
However, some limitations must be considered. First,
fluid balance before ICU admission was not measured,
which might influence the incidence of AKI and the out-
comes. Second, fluid gain could be the result of either
overzealous fluid therapy or poor urine output; we could
not differentiate between the two components. Third,
there are many factors that affect the prognosis of pa-
tients with AKI. Fluid balance is one of these factors,
and we need to perform a propensity analysis to further
explore this issue. In addition, we failed to determine the
type of fluid given (i.e., colloid versus crystalloid, paren-
teral versus enteral), aside from the volume, which may
have influenced outcomes. We also excluded patients
who had been in the ICU for fewer than 3 days but had
more severe illness, and our results could have been a
little more meaningful if we had included such patients.
Conclusions
This large, multicenter, observational study confirms
that higher fluid balance was an important factor associ-
ated with 28-day mortality among patients with AKI.
Fluid balance was higher in the AKI group than in the
non-AKI group. FO was an independent risk factor for
the incidence of AKI and increased the AKI severity.
Further studies are needed to investigate the mecha-
nisms underlying the role of fluid balance in patients
with AKI.
Key messages
 In this multicenter ICU study, fluid balance was
higher in the AKI group than in the non-AKI group.
 FO was an independent risk factor for the incidence
of AKI and increased AKI severity.
 A higher cumulative fluid balance was an important
factor associated with 28-day mortality following
AKI.
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